What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Schizophrenia
- Psychiatry
John M. Kane mainly investigates Psychiatry, Schizophrenia, Internal medicine, Psychosis and Antipsychotic.
Clozapine, Risperidone, Olanzapine, Atypical antipsychotic and Brief Psychiatric Rating Scale are the core of his Psychiatry study.
His Schizophrenia study combines topics in areas such as Pediatrics, Clinical psychology and Intensive care medicine.
His Internal medicine research incorporates themes from Aripiprazole, Placebo and Positive and Negative Syndrome Scale.
The concepts of his Psychosis study are interwoven with issues in First episode, Genetics, Neuroscience and Haplotype.
His Antipsychotic study combines topics from a wide range of disciplines, such as Clinical trial, Relapse prevention, Adverse effect, Polypharmacy and Fluphenazine.
His most cited work include:
- Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine (3267 citations)
- Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus (1524 citations)
- The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. (1335 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Psychiatry, Schizophrenia, Internal medicine, Antipsychotic and Psychosis.
Psychiatry is closely attributed to Clinical psychology in his work.
As part of the same scientific family, John M. Kane usually focuses on Schizophrenia, concentrating on Pediatrics and intersecting with Tardive dyskinesia.
As a part of the same scientific study, John M. Kane usually deals with the Internal medicine, concentrating on Placebo and frequently concerns with Tolerability.
John M. Kane interconnects Adverse effect and Clinical trial in the investigation of issues within Antipsychotic.
His studies deal with areas such as Anesthesia and MEDLINE as well as Clozapine.
He most often published in these fields:
- Psychiatry (65.92%)
- Schizophrenia (51.84%)
- Internal medicine (39.39%)
What were the highlights of his more recent work (between 2017-2021)?
- Schizophrenia (51.84%)
- Internal medicine (39.39%)
- Antipsychotic (30.51%)
In recent papers he was focusing on the following fields of study:
John M. Kane spends much of his time researching Schizophrenia, Internal medicine, Antipsychotic, Psychiatry and Psychosis.
John M. Kane does research in Schizophrenia, focusing on Clozapine specifically.
John M. Kane studied Internal medicine and Placebo that intersect with Tolerability and Adverse effect.
His Antipsychotic study also includes
- Tardive dyskinesia, which have a strong connection to Abnormal Involuntary Movement Scale,
- Incidence most often made with reference to Cohort.
His Psychosis research is multidisciplinary, incorporating perspectives in First episode, Neuroscience, Functional connectivity and Pediatrics.
In his work, Clinical psychology is strongly intertwined with Positive and Negative Syndrome Scale, which is a subfield of Randomized controlled trial.
Between 2017 and 2021, his most popular works were:
- Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression (188 citations)
- Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression (188 citations)
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? (82 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Schizophrenia
- Psychiatry
His scientific interests lie mostly in Schizophrenia, Internal medicine, Antipsychotic, Psychiatry and Psychosis.
His Schizophrenia research is multidisciplinary, relying on both Psychological intervention, Clinical trial, Regimen, Relapse prevention and Flexibility.
His Internal medicine course of study focuses on Placebo and Adverse effect, Tolerability, Antidepressant and Exacerbation.
His Antipsychotic research integrates issues from Clozapine, Tardive dyskinesia, MEDLINE, Aripiprazole and Intensive care medicine.
In his works, John M. Kane undertakes multidisciplinary study on Psychiatry and dup.
His biological study spans a wide range of topics, including Intervention, First episode and Disease mechanisms, Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
